KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Raw Materials (2019 - 2026)

Opko Health filings provide 8 years of Raw Materials readings, the most recent being $11.1 million for Q1 2026.

  • On a quarterly basis, Raw Materials rose 1.5% to $11.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $11.1 million, a 1.5% increase, with the full-year FY2025 number at $13.1 million, up 38.99% from a year prior.
  • Raw Materials hit $11.1 million in Q1 2026 for Opko Health, down from $13.1 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $29.3 million in Q2 2023 to a low of $6.8 million in Q4 2022.
  • Median Raw Materials over the past 5 years was $11.0 million (2025), compared with a mean of $12.7 million.
  • The widest YoY moves for Raw Materials: up 152.2% in 2024, down 68.39% in 2024.
  • Opko Health's Raw Materials stood at $6.8 million in 2022, then skyrocketed by 32.64% to $9.0 million in 2023, then grew by 4.87% to $9.4 million in 2024, then skyrocketed by 38.99% to $13.1 million in 2025, then fell by 15.14% to $11.1 million in 2026.
  • The last three reported values for Raw Materials were $11.1 million (Q1 2026), $13.1 million (Q4 2025), and $13.0 million (Q3 2025) per Business Quant data.